{
  "compound": "THC, CBD, HU-210 (synthetic)",
  "condition": "GLAUCOMA",
  "effect_size": "N/A (mechanistic)",
  "study_type": "MECHANISTIC",
  "source": "NORML:GLAUCOMA_MECHANISTIC_002",
  "participants": "In vitro and animal model study",
  "year": 2008,
  "notes": "Neuroprotective Effects of Cannabinoids on Retinal Ganglion Cells",
  "confidence": "medium",
  "abstract": "Cannabinoids protect RGCs from: glutamate excitotoxicity (40% improved survival), ischemia (35% improved survival), oxidative stress (45% improved survival)"
}